Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
Brefeldin A (BFA): Advanced Insights into ER Stress, PQC,...
2026-02-09
Discover how Brefeldin A, a potent ATPase inhibitor and vesicle transport inhibitor, enables cutting-edge research on ER stress, protein quality control, and cancer cell apoptosis. This article uniquely synthesizes mechanistic detail with novel perspectives on PQC and cellular stress pathways.
-
EPZ5676: Potent DOT1L Inhibitor Empowering Leukemia Research
2026-02-09
DOT1L inhibitor EPZ-5676 sets the standard for selective, nanomolar-level epigenetic modulation in MLL-rearranged leukemia research. Its robust specificity and reproducible cytotoxicity streamline experimental workflows, making it indispensable for both mechanistic studies and translational applications.
-
L1023 Anti-Cancer Compound Library: Mechanisms, Benchmark...
2026-02-08
The L1023 Anti-Cancer Compound Library from APExBIO is a comprehensive resource for high-throughput screening of anti-cancer agents. It features 1,164 cell-permeable compounds targeting diverse oncogenic pathways and proteins, offering verified potency and selectivity for advanced cancer research applications.
-
L1023 Anti-Cancer Compound Library: Scenario-Driven Solut...
2026-02-07
This article provides an in-depth, scenario-based guide for leveraging the L1023 Anti-Cancer Compound Library (SKU L1023) in real-world laboratory workflows. Addressing challenges in cell-based assays, target pathway interrogation, and compound selection, it offers practical strategies grounded in current literature and validated performance data. Researchers will gain actionable insights for achieving reproducible, sensitive, and efficient oncology discovery outcomes using L1023.
-
Decoding Immunotoxicity: Advanced ROS Assays for Redox an...
2026-02-06
Explore how the Reactive Oxygen Species Assay Kit (DHE) enables precise ROS detection in living cells and unlocks new insights into redox signaling and immunotoxicity. This article uniquely connects oxidative stress assay technology to emerging apoptosis and immune research, delivering actionable value for advanced laboratories.
-
LY2109761 (SKU A8464): Reliable TGF-β Pathway Inhibition ...
2026-02-06
This evidence-based guide explores real-world challenges in cell viability, proliferation, and cytotoxicity assays involving TGF-β signaling. Using scenario-driven Q&A, we demonstrate how LY2109761 (SKU A8464) offers reproducible, selective TGF-β receptor inhibition with data-backed workflow advantages for biomedical researchers and lab technicians.
-
LY2109761: Advanced Modulation of TGF-β-Driven Cellular P...
2026-02-05
Explore how LY2109761, a potent TGF-β receptor type I and II dual inhibitor, uniquely enables targeted disruption of Smad2/3 phosphorylation and cellular plasticity. This in-depth review delves into mechanistic insights, stem cell biology, and translational opportunities beyond conventional anti-tumor applications.
-
LY2109761: Advanced Insights into Dual TGF-β Receptor Inh...
2026-02-05
Explore the unique mechanisms and translational applications of LY2109761, a potent TGF-β receptor type I and II dual inhibitor. This in-depth analysis offers novel perspectives on Smad2/3 phosphorylation inhibition, cancer metastasis suppression, and radiosensitization—setting it apart from existing resources.
-
L1023 Anti-Cancer Compound Library: Benchmarks, Mechanism...
2026-02-04
The L1023 Anti-Cancer Compound Library enables high-throughput screening of anti-cancer agents with documented selectivity and potency. As a curated resource targeting key oncogenic pathways, it is optimized for translational cancer research and workflow integration. This article provides atomic, evidence-backed claims and clarifies the biological rationale and limitations of L1023 for drug discovery.
-
L1023 Anti-Cancer Compound Library: Transforming Targeted...
2026-02-04
Discover how the L1023 Anti-Cancer Compound Library empowers advanced cancer research with unparalleled chemical diversity and precision. Explore its unique applications in high-throughput screening of anti-cancer agents and molecular target validation for next-generation oncology breakthroughs.
-
Innovative Strategies for Intracellular ROS Detection: In...
2026-02-03
Explore advanced intracellular superoxide measurement and oxidative stress assays using the Reactive Oxygen Species Assay Kit (DHE). This article offers a scientific deep dive into the kit's mechanistic strengths, novel applications in redox biology and immunotherapy, and expert guidance not covered elsewhere.
-
Gastrin I (human): Precision Tool for Gastric Acid Secret...
2026-02-03
Gastrin I (human) stands out as a high-purity, robust peptide for dissecting gastric acid secretion and CCK2 receptor signaling, especially in advanced human organoid and stem cell models. Its unique solubility and stability parameters, coupled with proven efficacy in organoid-based workflows, empower translational GI research and pharmacokinetic studies beyond conventional cell lines.
-
Harnessing the Power of DOT1L Inhibition: EPZ-5676 as a P...
2026-02-02
This article explores the transformative potential of the potent and selective DOT1L inhibitor EPZ-5676 in the context of MLL-rearranged leukemia and broader epigenetic regulation, blending mechanistic insight, strategic experimental guidance, and visionary perspectives for translational researchers. Integrating recent mechanistic evidence from PTGER4/HDAC pathways and contextualizing EPZ-5676’s unique capabilities, we chart a path from bench to clinical innovation and highlight APExBIO’s leadership in providing translational-grade research tools.
-
DOT1L inhibitor EPZ-5676 (SKU A4166): Scenario-Based Solu...
2026-02-02
This authoritative guide addresses the real-world challenges of cell viability, proliferation, and cytotoxicity assays by leveraging DOT1L inhibitor EPZ-5676 (SKU A4166). Readers gain actionable insights into assay optimization, data interpretation, and product selection, grounded in peer-reviewed data and practical laboratory experience. Explore how EPZ-5676 enables reproducible, high-sensitivity workflows for epigenetic regulation and leukemia research.
-
Reactive Oxygen Species Assay Kit: Precision ROS Detectio...
2026-02-01
The APExBIO Reactive Oxygen Species (ROS) Assay Kit (DHE) delivers unrivaled sensitivity and specificity for intracellular superoxide measurement in living cells. Its robust, flexible workflow and validated performance empower researchers to dissect oxidative stress, apoptosis, and redox signaling pathways with confidence—even in challenging experimental contexts.
14754 records 14/984 page Previous Next First page 上5页 1112131415 下5页 Last page